<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The gene for von <z:e sem="disease" ids="C1406030" disease_type="Neoplastic Process" abbrv="">Recklinghausen</z:e> <z:hpo ids='HP_0001067'>neurofibromatosis</z:hpo> (NF1) is on proximal 17q; the location of the gene for <z:e sem="disease" ids="C0001080" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">achondroplasia</z:e> (ACH) is unknown </plain></SENT>
<SENT sid="1" pm="."><plain>We have begun a molecular analysis of a patient with <z:hpo ids='HP_0001249'>mental retardation</z:hpo>, NF1 and ACH, a clinical presentation suggestive of a <z:hpo ids='HP_0001466'>contiguous gene syndrome</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In addition, this individual has a 47,XYY chromosome constitution </plain></SENT>
<SENT sid="3" pm="."><plain>To define a possible chromosome 17 deletion, we investigated the copy number of DNA sequences linked to NF1 with conventional and pulsed-field gel electrophoresis (PFGE) </plain></SENT>
<SENT sid="4" pm="."><plain>We found no evidence for a deletion on chromosome 17 </plain></SENT>
<SENT sid="5" pm="."><plain>These results make it unlikely that this patient harbors a single deletion in the NF1 region causing both NF1 and ACH and suggest different mechanisms for the de novo occurrence of 2 <z:hpo ids='HP_0000006'>autosomal dominant</z:hpo> disorders in this individual </plain></SENT>
</text></document>